Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Medical Marijuana Inc.'s HempMedsPX to Attend and Exhibit at Michigan Medical Marijuana Conference



Medical Marijuana Inc.'s HempMedsPX to Attend and Exhibit at Michigan Medical
Marijuana Conference

HempMedsPX Will Enter "CBD Simple" Hemp Cannabidiol (CBD) Concentrate Into
Conference's Cannabis Competition in Traverse City on September 29, 2013

SAN DIEGO, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC
Pink:MJNA) is pleased to announce to shareholders and the general public that
HempMedsPX—a corporate portfolio company of Medical Marijuana Inc. and the
exclusive master distributor and contracted marketing company for CannaVest
Corp. (OTC:CANV) and Medical Marijuana Inc. — will be attending and submitting
product for judging at the Michigan Medical Marijuana Conference on September
29, 2013 in Traverse City, Michigan.

"This is our second MMM Conference, and we couldn't be more excited," said
Charles Vest, Director of Communications for HempMedsPX and keynote speaker at
the conference. "We got a tremendous response to our federally legal CBD-rich
hemp oil products at the previous conference in August. The Michigan Court of
Appeals ruling that prohibits most edible cannabis products has left an
enormous void in the market. Medical cannabis patients who are seeking
high-CBD hemp oils and products should know we offer the solution, while
allowing them to be in full compliance with state and federal law."

In addition to exhibiting at the conference, HempMedsPX will be submitting the
prototype high-CBD hemp oil concentrate, CBD Simple, for judging at the
conference's "Green Cup." CBD Simple recently took top CBD honors at the High
Times Medical Cannabis Cup in Seattle, Washington.  

The Traverse City conference will feature medical cannabis physician
certification, medical cannabis patient registration, a legislation panel,
classes, industry-related speakers and exhibitors. For more information on the
conference Michigan Medical Marijuana Conference, visit their website at
MIMedicalMarijuana.com. For more information or to purchase hemp CBD products,
please visit HempMedsPX.com or call 866-273-8502.

About HempMedsPX

HempMedsPX offers mainstream marketing, sales, customer service, and logistics
for the cannabis industry. HempMedsPX is a corporate portfolio company of
Medical Marijuana Inc. (OTC:MJNA) and the exclusive master distributor and
contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical
Marijuana Inc.. In addition to handling sales and distribution of hemp
cannabidiol (CBD) products, HempMedsPX is the communication hub for the
Medical Marijuana Inc. family of companies.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their
integrity and entrepreneurial spirit. We strive to create awareness within our
industry, develop environmentally friendly, economically sustainable
businesses, while increasing shareholder value. For more information, please
visit the company's website at: www.MedicalMarijuanaInc.com

About CannaVest Corp.

CannaVest Corp. (OTC:CANV) is in the business of investing and developing
hemp-based cannabinoid companies. CannaVest Corp. also develops, produces,
markets and sells end-consumer products to the nutraceutical industry
containing the hemp plant extract, cannabidiol (CBD). Additionally, the
company resells—to third parties—raw product acquired by CannaVest Corp.
pursuant to the company's supply relationships in Europe. CannaVest Corp.
seeks to take advantage of an emerging worldwide trend to re-energize the
production of industrial hemp and to foster its many uses for consumers.
Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and
CBD is derived from hemp stalk and seed. Additional information is available
from OTCMarkets.com or by visiting CannaVest.com.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to
diagnose, treat or cure any disease.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material contains
statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from
the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or
distribute any products that are in violation of the United States Controlled
Substances Act (US.CSA). These companies do grow, sell and distribute
hemp-based products and are involved with Federally Legal Distribution of
Medical Marijuana based products within certain international markets.

CONTACT: Investor relations contact:
         Stuart T. Smith
         SmallCapVoice.Com, Inc.
         P. 512-267-2430
         info@smallcapvoice.com
        
         Corporate contact:
         Medical Marijuana, Inc.
         Toll Free: 888-OTC-MJNA  (888-682-6562)
         www.medicalmarijuanainc.com
         www.facebook.com/mjnainc
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement